Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $99000.0.

  • Nephros' Free Cash Flow rose 11589.09% to $99000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 23102.95%. This contributed to the annual value of -$555000.0 for FY2024, which is 17380.32% down from last year.
  • Per Nephros' latest filing, its Free Cash Flow stood at $99000.0 for Q3 2025, which was up 11589.09% from $994000.0 recorded in Q2 2025.
  • Nephros' 5-year Free Cash Flow high stood at $1.3 million for Q4 2024, and its period low was -$1.8 million during Q1 2022.
  • Moreover, its 5-year median value for Free Cash Flow was -$170000.0 (2022), whereas its average is -$162210.5.
  • Per our database at Business Quant, Nephros' Free Cash Flow crashed by 224743.59% in 2022 and then skyrocketed by 57472.53% in 2024.
  • Quarter analysis of 5 years shows Nephros' Free Cash Flow stood at -$335000.0 in 2021, then skyrocketed by 41.79% to -$195000.0 in 2022, then tumbled by 40.0% to -$273000.0 in 2023, then soared by 574.73% to $1.3 million in 2024, then plummeted by 92.36% to $99000.0 in 2025.
  • Its Free Cash Flow was $99000.0 in Q3 2025, compared to $994000.0 in Q2 2025 and $322000.0 in Q1 2025.